Featured Articles

51. Benefits Of Electronic Labels: Investigational Medicinal Products 12/2/2022

    When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.

52. The TMF Management Vendor Oversight Checklist 11/8/2022

    Whether you are new to vendor management or a seasoned pro, we all need a set of fundamentals as a foundation. The list includes some additional TMF pro tips if your vendors are helping support your TMF management.

53. Lack Of Diversity in Clinical Trials: A Conversation 11/7/2022

    Check out key takeaways from this blog that include delving into the existing clinical landscape and what actions to take moving forward.

54. Plain Language Summary Of Clinical Trial Results: A Critical Tool In Medical Communication 10/19/2022

    This checklist will help guide your PLS development strategy and maximize team efficiencies to create a robust, long-term workflow that works for you and meets your timelines. 

55. The CTMS Gap: Improving The CTMS Experience For Study Teams 10/14/2022

    Study managers and CRAs want to be able to see timelines, visualize critical data, and have confidence in their ability to stay compliant. They want the system to provide a guided, automated path for task completion. How do we close this gap?

56. Reaching Diverse Patient Populations To Drive Inclusivity In Trials 10/14/2022

    There is a considerable diversity gap in clinical research. In order to pursue effective diversity strategies in clinical trial recruitment, it is critical to understand these barriers and develop a plan of action to remove them.

57. Plain Language Summary Requirements For Clinical Trials 10/14/2022

    Plain language summaries (PLS) of Clinical Trial Results are a critical tool in medical communication to help disseminate summarized, easy-to-digest research information to general audiences. Here are key insights into developing an effective PLS. 

58. Intellectual Property (IP) Strategies To Consider for Life Sciences Start-Ups 9/23/2022

    Intellectual property (IP) is one of the most valuable assets a life sciences innovator or start-up has. However, attracting the necessary capital can be tricky without first obtaining the appropriate protections for your IP.

59. Electronic Product Information: Everything You Need To Know 9/23/2022

    Learn about one of the latest initiatives being spearheaded by EMA is publishing ePI, or electronic product information.

60. 3 Benefits Of Centralizing Global Content For eCOA Migration 9/23/2022

    Learn why now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.